Advertisement
U.S. markets closed
  • S&P 500

    5,088.80
    +1.77 (+0.03%)
     
  • Dow 30

    39,131.53
    +62.42 (+0.16%)
     
  • Nasdaq

    15,996.82
    -44.80 (-0.28%)
     
  • Russell 2000

    2,016.69
    +2.85 (+0.14%)
     
  • Crude Oil

    76.57
    -2.04 (-2.60%)
     
  • Gold

    2,045.80
    +15.10 (+0.74%)
     
  • Silver

    22.98
    +0.19 (+0.84%)
     
  • EUR/USD

    1.0823
    -0.0005 (-0.04%)
     
  • 10-Yr Bond

    4.2600
    -0.0670 (-1.55%)
     
  • GBP/USD

    1.2673
    +0.0015 (+0.12%)
     
  • USD/JPY

    150.4400
    -0.0600 (-0.04%)
     
  • Bitcoin USD

    51,643.56
    +572.06 (+1.12%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,706.28
    +21.79 (+0.28%)
     
  • Nikkei 225

    39,098.68
    +836.48 (+2.19%)
     

Federal Agency Warns Outbreak Of Drug-Resistant Infections After Use Of OTC Artificial Tear Brand

  • The Centers for Disease Control and Prevention has issued a health advisory regarding multidrug-resistant bacterial infections due to artificial tears from a brand of nonprescription eye drops.

  • At least 55 patients in 12 states have been diagnosed with multidrug-resistant bacterial infections possibly linked to EzriCare Artificial Tears, the Centers for Disease Control and Prevention said Wednesday.

  • The CDC said that the infections had caused one death, permanent vision loss, and hospitalization in a health alert on its website.

  • CDC laboratory testing identified the presence of the outbreak strain in opened EzriCare bottles with different lot numbers collected from two states.

  • Patients and healthcare providers should immediately discontinue using EzriCare artificial tears pending additional guidance from CDC and the FDA.

  • EzriCare said it has stopped distributing and selling the eye drops.

  • The infections were caused by Pseudomonas aeruginosa, the CDC said, a bacterium highly resistant to antibiotics.

  • The CDC advised people who have used EzriCare Artificial Tears and who have symptoms of infection such as eye discharge, pain, or discomfort to seek medical care.

Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.

This article Federal Agency Warns Outbreak Of Drug-Resistant Infections After Use Of OTC Artificial Tear Brand originally appeared on Benzinga.com

.

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Advertisement